Ferric Carboxymaltose Injection [Ferinject]: Clinical Trials

4 trials of Ferric Carboxymaltose Injection [Ferinject], newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1
Phase 41Recruiting 1

Follow Ferric Carboxymaltose Injection [Ferinject]: new trials by email Literature Review of Ferric Carboxymaltose Injection [Ferinject] trials Research Report on Ferric Carboxymaltose Injection [Ferinject]

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia
Ferric Bepectate IV Injection, Ferric Carboxymaltose Injection [Ferinject], Ferric Carboxymaltose Injection [Injectafer®] - Iron Deficiency Anemia (IDA)
Phase 3Not yet recruitingAFT Pharmaceuticals, Ltd.13662026-12-012026-08-20
Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeI
Ferric Carboxymaltose Injection [Ferinject], Randomization, Questionnaire and Physical Exam - Restless Legs Syndrome (RLS)
Phase 2Not yet recruitingUniversity Hospital, Montpellier662026-10-012026-09-16
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Ferric Carboxymaltose Injection [Ferinject] - Acute Coronary Syndromes (ACS), Iron Deficiencies
Phase 4RecruitingFundación para la Investigación del Hospital Clínico de Valencia5382026-03-052026-03-24
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Ferinject] - Iron Deficiency, Anaemia
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd842023-10-092024-04-18

Conditions studied

Iron Deficiencies (2)  ·  Acute Coronary Syndrome (1)  ·  Anemia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Frailty (1)  ·  Myocardial Infarction (1)  ·  Restless Legs Syndrome (1)

Sponsors

AFT Pharmaceuticals, Ltd. (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (1)  ·  University Hospital, Montpellier (1)

Countries

Bulgaria (1)  ·  China (1)  ·  France (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Ioana Stanescu, Phil.Lic., MSc. (1)  ·  Li Xiang (1)